Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase III trial in hormone sensitive postmenopausal early breast cancer
https://www.powershow.com/view4/4b5d3d-ZTBkM/Results_of_the_first_planned_analysis_of_the_TEAM_tamoxifen_exemestane_adjuvant_multinational_prospective_randomized_phase_III_trial_in_hormone_sensitive_postmenopausal_early_breast_cancer_powerpoint_ppt_presentation
Icons create by Freepik from www.flaticon.com/